Individuals Coming Off Anti-Obesity Medications Regain Pounds at a Quadrupled Rate Than People Using Diet and Exercise

A recent study suggests that people who discontinue popular slimming jabs like semaglutide or tirzepatide tend to recover shed pounds much more quickly than those who end conventional lifestyle regimens.

Published data in a leading health publication shows that while overweight individuals often shed a large proportion of their body weight while on the medication, the weight comes back at an estimated rate of 0.8 kg per month once they quit.

"Users buying such drugs must be aware of the danger of rapid weight regain when the medication ends," cautioned lead investigator Dr. Susan Jebb.

This pace of regain means a return to original mass in about one and a half years.

Analyzing Approaches

The study, which examined 37 of trials involving over 9,000 of patients, contrasted the effects of the injectable medications with other pills.

Researchers note that individuals who lose weight through diet and exercise generally experience a less rapid creep back—approximately 100 grams monthly—once they finish.

Explaining the Fast Regain

Experts believe the mode of action of the injections is key to understanding the accelerated weight return.

These medications imitate a body's own chemical called glucagon-like peptide-1, which moderates appetite.

"Artificially providing GLP-1 concentrations several times higher than normal might result in the system to generate a reduced amount of its endogenous hormone, and may also diminish responsiveness to its actions," noted Dr. Adam Collins, a nutrition researcher.

"Withdrawal of this GLP-1 'fix' results in hunger is unsuppressed, making binge eating much more probable."

A Chronic Condition?

Health authorities suggest the injections for individuals with weight-linked medical conditions, accompanied by recommended lifestyle changes.

Many experts argue that, considering the high risk of relapse, the therapy should be considered long-term.

This perspective is supported by pharmaceutical companies, who note that the results "highlight the long-term nature of excess weight," akin to managing conditions like high blood pressure.

Patient Testimonies

People who have discontinued the medication report a sudden resurgence of hunger.

"I experienced a trigger that goes on and I was suddenly extremely hungry," said an individual.

This challenge is worsened if individuals have not developed lasting dietary or behavioural modifications during treatment.

Growing Use

Figures indicate that millions of adults in the UK have tried these injections in the past year, with desire remaining high.

• Use is more common among women compared to men.
• The 40s and 50s demographic shows the highest level of interest.
• Many access the drugs through private prescriptions rather than the NHS.

Finally, researchers caution that while GLP-1 drugs are potent agents for shedding pounds, they are not a permanent fix and long-term success likely depends on ongoing lifestyle management.